Macrophage Therapy Symposium


    Cancer immunology is establishing itself as the 5th pillar of oncology. T cell Therapies hitting the market have shown remarkable success, but their full potential is yet to be delineated. With patient responses limited in CAR-T treatment of solid tumors, the role of macrophages within the tumor microenvironment has come under increased scrutiny.

    The Macrophage Therapy Symposium will outline the key approaches for macrophage stimulation to limit immune suppression, angiogenesis and the resultant resistance to immune therapy.

    Tune in on March 23rd, to join key academics, innovative biotechs and pioneering pharmaceutical companies to meet and unpack the mechanisms and paradigms surrounding the key targets for macrophage modulation.

    Leading speakers include:

    • Tatiana Novobrantseva, Co-Founder & CSO, Verseau Therapeutics
    • Kipp Weiskopf, Whitehead Fellow, Whitehead Institute – MIT
    • Judith Varner, Professor – Pathology, UCSD
    • Nicolas Poirier, Chief Scientific Officer, OSE Immunotherapies
    • Yaron Pereg, CEO, Kahr Medical

    Rates to attend start from only $99, book early!

    Detailed Event Name: Macrophage Therapy Symposium
    Event Venue    : Virtual Summit
    Event start and end Date: 23 March, 2021
    Event website link: www.macrophagetherapy.com
    link to: https://go.kisacoresearch.com/l/678123/2021-01-06/4zzhk
    Complete Event Organizer Name: Kisaco Research
    Communication number (with country & area code):     +44 (0)20 3696 2920
    Email ID: events@kisacoresearch.com
    Social Media Link’s:
    https://www.linkedin.com/showcase/oncocelltherapyseries

    Organiser: Kisaco Research


    Kisaco Research works with the early adopters and leaders of growth markets in driving their respective industries forward and in providing the right knowledge, learning and social opportunities to stimulate business growth quickly and effectively.

    Kisaco Research produces, designs and hosts B2B industry conferences and exhibitions. Our platforms are neutral, so that our attendees get the right information from the most relevant people.